Clinical Trials Logo

Citation(s)

Phase II Study of High-dose (86 Gy)Intensity Modulated Radiotherapy and Concurrent Paclitaxel and Cisplatin in Locoregionally Advanced Esophageal Cancer

Details for clinical trial NCT03535207